Bedside brain monitor study for sedated ICU patients
Part of Brain & nervous system, Mental health clinical trials.
This study tests a new bedside monitoring system that tracks brain activity in ICU patients who are on a breathing machine and receiving sedative medications. It aims to help doctors better manage sedation and improve patient care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are on a breathing machine and expected to need it for at least 48 hours
- You are receiving sedative medications through an IV drip
- You are able to consent yourself or have a legally authorized representative consent for you
- You do not have severe hearing problems, a rash on your forehead, a history of multiple drug abuse, or severe dementia
- Doctors are not planning to withdraw life support within the next 24 to 48 hours
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a special monitor (BIS) that tracks brain activity in patients on breathing machines and sedation. The goal is to see if it helps doctors provide better sedation care.
This study tests how well a special brain-monitor (EEG) can be used to assess delirium in people in the ICU. It may help improve delirium detection and monitoring in critically ill patients.
This trial uses EEG (a painless head sensor test) to study brain activity during anesthesia or sedation in both children and adults. The goal is to better understand how the brain responds to these medicines, which may help improve future care.
This trial tests whether a sleep medication called lormetazepam can improve sleep quality and brain activity in ICU patients who are on a breathing machine. It may help if you need sedation and are expected to stay in the ICU for at least two days.
This study tests a “goal-directed” approach to sedation (giving the right amount based on target goals) for children who need a breathing machine in the pediatric ICU. The goal is to reduce brain and recovery side effects while keeping children comfortable and safe.
This study tests if adding a calming medicine called dexmedetomidine to a sleep-promoting routine can help reduce delirium in ICU patients who are awake and on a breathing machine or high-flow oxygen.
Hear when a new Delirium trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.